BRD4 and acute myeloid leukemia: More interestingly, recent studies have also showed that BRD4 activation may also predict the overall survival of patients with several tumors, such as melanoma, hepatocellular carcinoma, multiple myeloma, Burkitt's lymphoma, acute myeloid leukemia and breast cancer [12–17].